:bear: ZBH: Massive $1.2M Bearish Put Bet Lands Right at Support - Institutional Money Smells Trouble!

:calendar: January 23, 2026 | :fire: EXTREMELY UNUSUAL Activity Detected

---

:dart: The Quick Take

Someone just dropped $1.2 MILLION on ZBH puts betting the stock breaks below $85 by March expiration - and this trade is absolutely wild. We're talking roughly 338x the average activity level for this strike. This is the kind of trade that shows up maybe once or twice a year, and it landed precisely at the stock's gamma support level right before Q4 earnings on February 10. Big money is positioning for a breakdown.

---

:office: Company Overview

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) is a medical device heavyweight specializing in orthopedic reconstructive implants and surgical equipment. They're the market leader in both knees (33% share) and hips (25% share) - essentially, if grandma needs a new hip, there's a 1-in-4 chance it's coming from Zimmer Biomet.

The company has been navigating choppy waters lately - stock dropped 13% on November 5, 2025 after missing Q3 revenue expectations and lowering guidance. They're currently trading near 52-week lows around $87, down roughly 24% from October highs of ~$115.

---

:moneybag: The Option Flow Breakdown

:chart_with_upwards_trend: The Trade Tape

Stock: :chart: ZBH on Ainvest

:nerd_face: What This Actually Means

Let's break down why this trade is screaming for attention:

:fire: 338x normal activity - Translation: This volume is 338 times higher than the normal activity level for this strike. You might see activity this unusual maybe 1-2 times per year across all options markets. This isn't your neighbor's Robinhood account - this is serious institutional money making a very deliberate bet.

:whale: Vol/OI Ratio of 18.5 - Volume is nearly 19x the open interest, meaning this is almost entirely NEW positions being opened, not existing holders adjusting.

:bear: BTO (Buy-to-Open) - This is a fresh bearish position. Someone paid $1.2M in premium expecting ZBH to drop below $85 by March 20, 2026.

:dart: $85 Strike = Exactly at Gamma Support - This isn't random. The $85 level is the strongest gamma support on the board. If this breaks, there's a lot of open air below.

---

:chart_with_upwards_trend: Technical Setup / Chart Check-Up

YTD Chart Analysis

ZBH has been in a brutal downtrend since October 2025. The stock peaked around $114-115 and has systematically broken every support level on the way down. Currently trading at $86.35, we're hovering just above the critical $85 support that this massive put bet is targeting.

The 24% decline in 3 months tells a clear story - institutions have been de-risking ahead of earnings and the "cautious 2026 outlook" that management previewed at the J.P. Morgan Healthcare Conference.

:bar_chart: Gamma-Based Support & Resistance Analysis

Current Price: $86.35

GEX Bias: BEARISH - Put gamma (0.928) exceeds call gamma (0.836), meaning market makers are positioned for downside moves. When puts dominate gamma exposure, any selling pressure gets amplified as dealers hedge.

:point_right: The $85 Level is Critical - This is where the massive put bet landed, and it's also the strongest gamma support. If ZBH breaks below $85, there's a gamma vacuum down to $80. The put buyer is betting on exactly this scenario.

:crystal_ball: Implied Move Analysis

The March 20 expiration (same as the put trade) has an implied move of ±8.51%. This means the market is pricing in ZBH potentially trading anywhere from $79.31 to $94.05 by expiration.

:thinking: Key Insight: The $85 put strike is within the 1-sigma expected move. For this trade to print big money, ZBH needs to drop below $85 - that's only a 1.6% decline from here, well within normal volatility. The put buyer gets max pain if we see the full implied move to $79.31.

---

:circus_tent: Catalysts

:calendar: Upcoming Catalysts (The Big Ones)

:rotating_light: CRITICAL TIMING: The March 20 put expiration is AFTER the February 10 earnings. This bet is positioned to capture any earnings-related selloff with time to spare. Management already signaled "tempered enthusiasm" for 2026 at the J.P. Morgan Healthcare Conference - if the actual guidance disappoints, $85 support could snap fast.

:rewind: Recent Catalysts (Already Happened)

The Q3 2025 earnings disaster is still fresh - revenue missed, emerging markets collapsed with distributor order cancellations, and management lowered full-year organic growth to 3.5%-4.0%. The put buyer likely expects a repeat performance.

---

:game_die: Price Targets & Probabilities

Using our gamma levels, implied moves, and catalyst calendar, here's how the scenarios stack up:

:bear: Bear Case: $79-80 (Target: $79.31)

Probability: 35%

If Q4 earnings disappoint like Q3 did, and management delivers the "cautious" 2026 outlook they previewed, breaking $85 support triggers a cascade to $80. Goldman Sachs already downgraded to Sell with a $93 target - a move to $80 would validate the most bearish analyst calls.

:balance_scale: Base Case: $82-88 (Sideways Chop)

Probability: 45%

The most likely scenario is ZBH bouncing between gamma support ($85) and near-term resistance ($90). Q4 earnings come in mixed - beat on EPS, miss or meet on revenue - and 2026 guidance is "cautious but not catastrophic." Stock holds the $85 level but lacks catalyst to push higher.

:rocket: Bull Case: $94-100 (Recovery Rally)

Probability: 20%

Would require a beat-and-raise quarter with upside 2026 guidance. The ROSA Knee OptimiZe launch and DTC campaign featuring Arnold Schwarzenegger would need to translate into real procedure volume growth. BTIG maintains a Buy with $112 target but this feels like a stretch in the current sentiment environment.

---

:bulb: Trading Ideas

:shield: Conservative: "Watch and Wait" Cash-Secured Put

The Setup: If you're bullish on ZBH long-term, sell the Feb 20 $80 put after earnings if the stock holds $85 support

:point_right: Best For: Long-term investors who like ZBH's 33% knee market share and want to accumulate on weakness. Wait for earnings clarity before deploying.

:balance_scale: Balanced: "Ride the Whale" Put Spread

The Setup: Follow the institutional money with a defined-risk bearish spread

:point_right: Best For: Traders who believe the $1.2M put buyer knows something but want capped risk. You're essentially buying the same strike as the whale but funding it by selling the lower strike. Win if ZBH breaks below $85 toward $80.

:rocket: Aggressive: "Full Send" Naked Put Purchase

The Setup: Match the institutional trade directly

:point_right: Best For: High-conviction bears who believe Q4 earnings will disappoint AND 2026 guidance will spook the street. You need a 5-6% decline to profit. The 338x-activity whale is betting heavily on exactly this outcome.

---

:warning: Risk Factors

:rotating_light: What Could Go Wrong

:x: Earnings Beat: If ZBH delivers a clean Q4 with upbeat 2026 guidance, the stock could squeeze to $90+ and this put bet goes to zero fast.

:x: Short Squeeze Potential: 88.89% institutional ownership means the float is tight. Any positive surprise could trigger aggressive covering.

:x: Theta Decay: This put expires in 56 days. If ZBH just sits at $86 through mid-February, the put loses value daily. Time is not the buyer's friend.

:x: Acquisition Rumors: With J&J spinning off its orthopedics business, consolidation speculation could boost ZBH unexpectedly.

:x: Technical Bounce: $85 is strong gamma support. Market makers will defend this level initially, potentially frustrating the put buyer in the short term.

:x: Lawsuit Overhang: The Hagens Berman securities investigation and Deloitte ERP lawsuit create headline risk in either direction.

---

:dart: The Bottom Line

Real talk: Someone with very deep pockets just made a $1.2M bet that Zimmer Biomet breaks down below $85 by March. This isn't speculation - activity at 338x normal means this kind of trade shows up maybe once or twice a year. They positioned precisely at gamma support, timed for earnings, with enough runway to capture any Q4 disappointment.

Here's Your Game Plan:

The Key Levels:

• :rotating_light: Critical Support: $85 - Break here and $80 comes fast
• :octagonal_sign: Resistance: $90 - Need earnings beat to test
• :calendar: Key Date: February 10 - Q4 earnings at 8:30 AM ET

Final Thought: When institutional money drops $1.2M on a single trade with activity 338x normal levels, they're not guessing. They have a thesis. Whether it's insider knowledge, superior analysis, or just conviction on the Q3 playbook repeating - this is a trade worth watching closely. The $85 level is about to be tested, and 56 days isn't a long time to wait for the answer.

---

:warning: Disclaimer: Options involve significant risk and are not suitable for all investors. This analysis is for educational purposes only and does not constitute financial advice. Past unusual options activity is not predictive of future stock performance. Always do your own due diligence and consider consulting a financial advisor before trading options.

---